Curis
CRIS
#11244
Rank
NZ$2.58 M
Marketcap
NZ$1.07
Share price
9.39%
Change (1 day)
-58.92%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): NZ-$24.95

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$25.25. In 2025 the company made an earnings per share (EPS) of NZ-$42.28 an increase over its 2024 EPS that were of NZ-$249.65.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$24.95-40.99%
2025NZ-$42.28-83.07%
2024NZ-$249.65-22.15%
2023NZ-$320.67-26.17%
2022NZ-$434.3022.3%
2021NZ-$355.11-25.37%
2020NZ-$475.85-30.93%
2019NZ-$688.92-2.02%
2018NZ-$703.13
2016NZ-$1,598-10%
2015NZ-$1,776138.1%
2014NZ-$745.7440%
2013NZ-$532.67-25%
2012NZ-$710.2366.67%
2011NZ-$426.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.35-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.06-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.64-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.86-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.72-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$5.65-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$6.11-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA